|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1-2
|
|
pubmed:dateCreated |
2007-12-24
|
|
pubmed:abstractText |
Previously, bis(alpha-furancarboxylato)oxovanadium(IV)(BFOV) exhibited potent hypoglycemic activity in diabetic animals. We evaluated the effects of BFOV on lipolysis in isolated rat adipocytes and lipid metabolism in fat-fed/streptozotocin (STZ)-induced diabetic rats, an animal model of type 2 diabetes.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0009-8981
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
388
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
89-94
|
|
pubmed:meshHeading |
pubmed-meshheading:17991430-Adipocytes,
pubmed-meshheading:17991430-Animals,
pubmed-meshheading:17991430-Diabetes Mellitus, Experimental,
pubmed-meshheading:17991430-Lipolysis,
pubmed-meshheading:17991430-Models, Molecular,
pubmed-meshheading:17991430-Molecular Conformation,
pubmed-meshheading:17991430-Organometallic Compounds,
pubmed-meshheading:17991430-Rats,
pubmed-meshheading:17991430-Rats, Sprague-Dawley
|
|
pubmed:year |
2008
|
|
pubmed:articleTitle |
The antilipolytic action of bis(alpha-furancarboxylato)oxovanadium(IV) in adipocytes.
|
|
pubmed:affiliation |
Yunnan Pharmacological Laboratories of Natural Products, Kunming Medical College, Kunming, PR China.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
